Pharmagene Overview

  • Founded
  • 2005

Founded
  • Status
  • Public

  • Employees
  • 34

Employees
  • Stock Symbol
  • 7595

Stock Symbol
  • Share Price
  • $0.46

  • (As of Friday Closing)

Pharmagene General Information

Description

Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Stock Exchange
ROCO
Primary Office
  • 4F., Number 17, Lane 171, Sector 2, Jiuzong Road
  • Neihu District
  • Taipei, 114
  • Taiwan
+886 02 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmagene Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.46 $0.47 $0.45 - $0.87 $19.8M 43.5M 31.6K -$0.03

Pharmagene Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 22,949 25,071 32,841
Revenue 4,420 4,629 3,443 2,112
EBITDA (710) (320) 94 (848)
Net Income (1,321) (839) (381) (1,136)
Total Assets 13,026 15,137 16,130 5,750
Total Debt 437 532 775 626
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharmagene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmagene‘s full profile, request access.

Request a free trial

Pharmagene Patents

Pharmagene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20070298426-A1 Warfarin dosage prediction Inactive 02-Jun-2006 0000000000
AU-2013219191-A1 Hla alleles associated with adverse drug reactions and methods for detecting such Inactive 11-May-2006
AU-2007249225-B2 Hla alleles associated with adverse drug reactions and methods for detecting such Active 11-May-2006 0000000000
AU-2007249225-A1 Hla alleles associated with adverse drug reactions and methods for detecting such Active 11-May-2006 0000000000
CA-2651954-C Hla alleles associated with adverse drug reactions and methods for detecting such Active 11-May-2006 C12Q1/6881
To view Pharmagene’s complete patent history, request access »

Pharmagene Executive Team (5)

Name Title Board Seat Contact Info
Sophia Jan General Manager & Chief Executive Officer
Yuanchong Chen MD Founder
Jin-Jer Chen Chairman
You’re viewing 3 of 5 executive team members. Get the full list »

Pharmagene Board Members (1)

Name Representing Role Since
Jin-Jer Chen Pharmagene Chairman 000 0000
To view Pharmagene’s complete board members history, request access »

Pharmagene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial